Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of rat

Drug Metabolism and Disposition

Volumn 28, Issue 2, 2000, Pages 205-208

  Le Doze, François ^b   Debruyne, Daniele ^a   Albessard, Françoise ^b   Barre, Louisa ^b   Defer, Gilles Louis ^b  

^a CHU CÔTE DE NACRE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; ISOTRETINOIN; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISPOSITION; DRUG HALF LIFE; GLIOBLASTOMA; GRAY MATTER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WHITE MATTER;

ANIMALS; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FENRETINIDE; HALF-LIFE; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; TRETINOIN;

ANIMALIA;

EID: 0033956665     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD and Wilson CB (1998) Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42:709-720.
2. Besner JG, Leclaire R, Band P, Meloche S, Deschamps M, Mailhot S, Moisan R and Diorio G (1985) Single-dose pharmacokinetic study of 13-cis-retinoic acid in man. Cancer Treat Rep 69:275-277.
3. Chandraratna RA (1998) Current research and future developments in retinoids: Oral and topical agents. Cutis 61:40-45.
4. Chang SM, Kuhn JG, Robins HI, Schold SC, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Schiff D, Gilbert M, Rankin C and Prados MD (1999) Phase II study of phenylacetate in patients with recurrent malignant glioma: A North American Brain Tumor Consortium report. J Clin Oncol 17:984-990.
5. Chou R, Burgin H, Schmitt G and Eggers H (1997) Absorption of tretinoin in rats and rabbits following oral and dermal application. Arzneim-Forsch 47:401-405.
6. Colburn WA, Gibson DM, Wiens RE and Hanigan JJ (1983) Found increases the bioavailability of isotretinoin. J Clin Pharmatol 23:534-539.
7. Defer GL, Adle-Biassette H, Ricolfi, Martin L, Authier FJ, Chomienne C, Degos L and Degos JD (1997) All-trans retinoic acid in relapsing malignant gliomas: Clinical and radiological stabilization associated with the appearance of intratumoral calcifications. J Neurooncol 34:169-177.
8. Dirks PB, Patel K, Hubbard SL, Ackerley C, Hamel PA and Rutka JT (1997) Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells. Oncogene 15:2037-2048.
9. Forinelli F, Clerici M, Campa T, Di Mauro MG, Magni A, Mascotti G, Moglia D, De Palo G, Costa A and Veronisi U (1993) Five-year administration of fenretinide: Pharmacokinetics and effects on plasma retinol concentrations. J Clin Oncol 11:2036-2042.
10. Friedman HS, Kerby T, Fields S, Zilisch JE, Graden D, McLendon RE, Houghton PJ, Arbuck S, Cokgor I and Friedman AH (1999) Topotecan treatment of adults with primary malignant glioma. The brain tumor center at Duke. Cancer 85:1160-1165.
11. Guchelaar HJ, Wouda S, Beukeveld GJ, Mulder NH and Oosterhuis JW (1992) Pharmacokinetics of parenteral 13-cis-retinoic acid formulations in rats. J Pharm Sci 81:432-435.
12. Hultin TA, May CM and Moon RC (1986) N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice. Drug Metab Dispos 14:714-717.
13. Irving H, Lovat PE, Hewson QC, Malcolm AJ, Pearson AD and Redfern CP (1998) Retinoid-induced differentiation of neuroblastoma: Comparison between LG69, an RXR-selective analogue and 9-cis retinoic acid. Eur J Cancer 34:111-117.
14. Kaha SE, Kyritsis AP, Conrad C, Gleason MJ, Newman R, Levin VA and Yung WK (1997) The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin). J Neurooncol 34:145-151.
15. Kalin JR, Milton E, Starling and Hill DL (1981) Disposition of all-trans-retinoic acid in mice following oral doses. Drug Metab Dispos 9:196-201.
16. Kligman AM (1998) The growing importance of topical retinoids in clinical dermatology: A retrospective and prospective analysis. J Am Acad Dermatol 39:S2-S7.
17. Liang JY, Fontana JA, Rao JN, Ordonez JV, Dawson MI, Shroot B, Wilber JF and Feng P (1999) Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3. Prostate 38:228-236.
18. Mologni L, Ponzanelli I, Bresciani F, Sardiello G, Bergamaschi D, Gianni M, Reichert U, Rambaldi A, Terao M and Garattini E (1999) The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphtalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases. Blood 93:1045-1061.
19. Orfanos CE, Ehlert R and Gollnick H (1987) The retinoids. A review of their clinical pharmacology and therapeutic use. Drugs 34:459-503.
20. Regazzi MB, Iacona I, Gervasutli C, Lazzarino M and Toma S (1997) Clinical pharmacokinetics of tretinoin. Clin Pharmacokinet 32:382-402.
21. Shelley RS, Jun HW, Price JC and Cadwallader DE (1982) Blood levels studies of all-trans- and 13-cis-retinoic acids in rats using different formulations. J Pharm Sci 71:904-907.
22. Swanson BN, Zaharevitz DW and Sporn MB (1980) Pharmacokinetics of N-(4-hydroxyphenyl)-all-trans-retinamide in rats. Drug Metab Dispos 8:168-172.
23. Wang C-C, Campbell S, Furner RL and Hill DL (1980) Disposition of all-trans- and 13-cis-retinoic acids and N-hydroxyethylretinamide in mice after intravenous administration. Drug Metab Dispos 8:8-11.
24. Weber E, Ravi RK, Knudsen ES, Williams JR, Dillehay LE, Nelkin BD, Kalemkerian GB, Feramisco JR and Mabry M (1999) Retinoic acid-mediated growth inhibition of small cell lung cancer cells is associated with reduced myc and increased p27Kip1 expression. Int J Cancer 80:935-943.
25. Wyss R (1990) Chromatography of retinoids. J Chromatogr 531:481-508.
26. Yung WK, Kyritsis AP, Gleason MJ and Levin VA (1996) Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid. Clin Cancer Res 2:1931-1935.
27. Zheng Y, Kramer PM, Lubet RA, Steele VE, Kelloff GJ and Pereira MA (1999) Effect of retinoids on AOM-induced colon cancer in rats: Modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis 20:255-260.